Report
VOLUNTIS | BUY Coverage Initiated | Pioneering Digital Therapeutics
Voluntis pioneers the digital therapeutics market, the fastest growing segment of the digital health market, set to grow over 20% p.a. to c.EUR9bn by 2022e and which features high barrier to entry (clinical development process and regulatory approval). The company’s solutions allow physicians and patients to better monitor treatments, ultimately increasing clinical outcome and reducing the cost for the payers.
Provider
Bryan Garnier
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Hugo Solvet
Other Reports from Bryan Garnier
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.